Stock Holders an Investors Dream, please read

Stock Holders an Investors Dream, please read

[TimCar]

  To read the most current research report , visit 
  http://208.142.202.16/eptctwo.html

Web Site could be down due to re-construction. If so lookup charts anywhere.

   - - - - - - - - - - - - - - - - - - - - - - - - - - 
  Company :Environmental Products & Technologies
  Symbol: EPTC
  Exchange:OTC:BB
  52 Week Low-High: $2.00 - $10.25
  Current Price $2.75
  
 - - - - - - - - - - - - - - - - - - - - - - - - - - 

 Wall Street Corner and Phoenix Group International recommend EPTC as
 stock to watch.


  Consumers, Federal and State Government and Local Pollution control
  Boards are making the clean up of wastes that pollute the water supply a major
  priority. There are over 30,000 farms that need to become compliant with
  Federal clean water laws over the next three year! s. Food wastes for
  restraints and food processors will n! o longer be accepted by landfills 
  in many states past December 31, 2000. The solution to these problems
  represents an major multi-billion dollar opportunity.


  EPTC was established to solve environmental problems regarding the safe
  conversion and removal of waste created by large livestock, poultry, and
  food producers and similar operations.


  Environmental Products & Technologies Corporation (EPTC) is a diversified
  agribusiness manufacturing company has developed and is selling a
  Closed-loop Waste Management Process for livestock operations and food 
  production that solves this waste problem. The system separates solid from
  liquid, processing the solids into an extent-pathogen-free, nutrient-rich
  soil amendment in less than three days -- in contrast to weeks or months for
  conventional systems.


  In early December 1999 EPTC announced a sale of Closed-loop Waste
  Management System for use in process! ing food waste from various supermarkets 
  and restaurants on the island of Oahu. The sale, valued in excess of $500,000
  provides for delivery and installation of a dual vessel Bioreactor system
  during the first quarter of 2000. The system is capable of processing
  approximately 25 tons of organic waste (including food, dairy, and green
  waste) per day. The purchaser anticip ates the purchase of up to 20
  additional systems after the initial systems are operating at full capacity.
  That could mean additional sales of $4 million to this one customer
  alone.


  A recent strong buy recommendation given to EPTC by The Phoenix Group 
  International and Wall Street Corner is one that should not be ignored. At a 
  recent price of $2.50 per share down from over $10.00 in mid-1999, the stock ( based on 
  recent chart action) looks to be ready for a move to the upside. Based on information
  announced by the company and the recently updated research report, the stock 
  ( http://208.142.202.16/eptctwo.html ) has potential for a move to new highs as the backlog of contracts
  for its waste manage system is anticipated to grow in the coming months.


  We believe that now is the time to take a close look at the
  shares of EPTC ( http://208.142.202.16/eptc.html ) . Approximately 8.5 million 
  shares outstanding and a $20 million market capitalization. Based on EPTC's 
  statement that it could sell and install close to 50 units during in 2000 the company 
  is selling at about 1.2 times anticipated sales. The multi-billion market for the company's
  products could produce extremely rapid growth from a flood of customers in
  great need of a solution to keep their businesses operational come January
  2001.



  The buy recommendation points out that EPTC's time has come. This does
  not refer solely to product design or the company's ability to deliver at least
  50 complete systems in the during 2000. It is expected that each of these
  systems will range for $250,000 t o $450,000 depending on the specific
  needs of the customer.


  The time has come refers to the attitude that consumers and even more
  importantly government at all levels has finally adopted.
  Laws and rules that have been on the books for years are finally receiving
  major attention and are starting to be enforced to the letter of the law.


  Government has also recognized that some of these laws are changes to
  prior rules and enforcement attitudes. To help encourage business and farms to
  invest in modern waste handling system they have provided financing
  programs to many regions in t! he form of very favorable long term, low
  cost loans, and! bond financing.


  Food wastes produced by food processors and restaurants in many cities
  and states such as California will soon no longer be accepted at land fills
  after December 31, 2000.


  This waste will require special handling and in many cases the EPTC Closed
  Loop Waste Management system may be the only alternative. The needs of
  the high density hog, dairy, and cattle raising industry have been highlighted
  by many problems this past year. The most important to regulators in the
  potential damage that these operation may cause to the water supply if the
  waste in not handled in a safe manner.


  This is not a recommendation to buy or sell the shares of Environmental
  Products and Technologies. The shares of this company should be
  considered high risk. This notice serves as a bulletin to advise our readers of a 
  possible opportunity in the environmental waste management business.


  We advise our readers to always research carefully and consult
  an investment professional before making investment decisions. For
  additional information investors should read the latest research report at
  http://208.142.202.16/eptctwo.html

Web Site could be down due to re-construction. If so lookup charts anywhere.

  or send us an E-mail at stocksavvyforum@myanmars.com
  or call (888) 323-0856 for more info today.
  

   

 

Stock Holders an Investors Dream, please read

[TimCar]

ImmuNis Corp a small Biotech Stock with Big Potential.
http://208.142.202.16

The Stock Savvy Investor Forum recommends that you
evaluate the investment potential of ImmuNis Corp shares.

ImmuNis Corp (OTCBB: IMMCE), owns a major interest
in a new class of oral diabetes medication. The drug is referred to as        
DIAB II and has been approved for sale in China and is the final             
stages of the application and registration process in Brazil. 

ImmuNis purchased its 25% interest in the commercial rights
to DIAB II in 1998 for territories outside of Oriental Asia. DIAB II       
is an insulin-receptor sensitizer, a new class of drugs for        
controlling the chronically high blood sugar levels that typify        
adult-onset or Type II diabetes. DIAB II works by improving the        
patient's ability to utilize both endogenous and
injected insulin, the hormone that controls blood sugar levels.

Adult-Onset Diabetes is an illness affecting more than 15
million Americans and more than 150 million people around the world.        
The drug - DIAB II - provides excellent control of diabetes symptoms        
without the side-effects of many competing drugs that are already on  
the market. 

ImmuNis Corp. has about 8.5 million shares outstanding and
at $1.50 per share price has a market capitalization of under $15        
million in a market segment where the majority of companies trade with        
$100 million valuations in anticipation of a new discovery or               
development. DIAB II confirmed the DIAB II is safe and effective. 

The market for Type II diabetes drugs is over $15 billion
annually. We believe that one should carefully evaluate the potential        
for a much higher stock market valuation of ImmuNis's share price.        
Many analysts are pointing out that companies like ImmuNis with the        
potential of success could produce gains comparable to what has been        
realized in the Dot Com sector.

DIAB II was developed by Biotech Holdings Ltd., a
Canadian-based pharmaceutical company, which controls the 
worldwide manufacturing and marketing rights to the drug. 

In a June 9, 1999 announcement Biotech also pointed out
that there is a sizable and very lucrative market potential for DIAB       
II in Brazil and throughout Latin America -- that for each one percent        
of the diabetic population in Brazil, Argentina and Venezuela using        
DIAB II (a total of 100,000 one-year prescriptions) -- DIAB II sales         
revenues generated would be over $20,000,000 annually. ImmuNis has a        
25% interest in all net revenues from the sale of DIAB II in these        
Latin American Territories as well as in North America and Europe.

In addition to its focus on Latin American markets where
license agreements have been completed in Brazil with Biobras, which        
is the fourth largest insulin manufacturer in the world with 75% of       
the diabetes medication market in Brazil. Agreements have also been          
completed in Argentina, Venezuela, Peru and Chile.

An agreement with a major (more than $10 billion in sales)
pharmaceutical company was announced in September of 1999, that
foresees potential licensing of DIAB II, for the U.S. market. Biotech        
expects to be working closely with this prospective licensing partner       
to review data and arrange for testing of DIAB II. The goal is to        
reach a licensing agreement that would provide for testing of DIAB II        
and filing of an application with the U.S. FDA, with the possibility        
that other markets could also be included in a final agreement.

Biotech Holdings completed the first phase of its drug
production facility Canadian Health Pr otection 
Branch, that certifies that Biotech has met GMP (Good
Manufacturi in Richmond, B.C. This notice of approval brings DIAB II        
to the final stages of entering the market in Brazil and throughout        
Latin American. Registration dossiers for the sale of DIAB II are now        
planned for submission in Chile, Argentina, Venezuela and Peru.        
Registration filings are also expected in the Middle East, Southern        
Europe and Africa.

The DIAB II Brazilian clinical trials provided supplementary
information for the regulatory application for approval of DIAB II, in        
Brazil as a prescription treatment for Type II or Adult-Onset        
Diabetes. The trial was carried out by one of the largest independent        
contract research laboratories in Brazil, working with Brazilian             
doctors specializing in diabetes. The trials showed that during DIAB        
II treatment that no adverse clinical events were reported. Plasma       
insulin, HDL/LDL ratio and triglycerides were controlled equally well        
with DIAB II treatment as on the patients' accustomed medication. The        
critical Hb A1c measurement showed reduced levels during the course of the 
study, to an average of 5.85%, (well within normal ranges) indicating 
excellent diabetic control

The shares of ImmuNis represent a opportunity for very
substantial gains.  However, the shares must be regarded as        
speculative. Even though the indications are that the drug will        
continue to prove to be safe and effective, obtaining final approval        
for sale and distribution in Western Countries may take time or may        
not occur at all. We always recommend that one investigate and        
evaluate the potential and risks of any investment. 

              http://208.142.202.16

Web Site could be down due to re-construction. If so lookup charts anywhere.

         or send us an E-mail at   ebi@katchup.co.nz
       or call (714) 887-2785 for more info

Nothing in this e-mail shou ld be construed as a solicitation.
Please consult an investment professional.
This is for INFORMATIONAL purposes only.

The Stock Savvy Investor takes pride in our careful efforts
to reach people who are truly interested in what we have to offer. 
You have received this message via a news service subscription or an       
affiliation of such. If in error, please delete hit button for removal
       

Stock Holders an Investors Dream, please read

[DarlaSmith]

  To read the most current research report , visit 
  http://208.142.202.16/eptctwo.html

Web Site could be down due to re-construction. If so lookup charts anywhere.

   - - - - - - - - - - - - - - - - - - - - - - - - - - 
  Company :Environmental Products & Technologies
  Symbol: EPTC
  Exchange:OTC:BB
  52 Week Low-High: $2.00 - $10.25
  Current Price $2.75
  
 - - - - - - - - - - - - - - - - - - - - - - - - - - 

 Wall Street Corner and Phoenix Group International recommend EPTC as
 stock to watch.


  Consumers, Federal and State Government and Local Pollution control
  Boards are making the clean up of wastes that pollute the water supply a major
  priority. There are over 30,000 farms that need to become compliant with
  Federal clean water laws over the next three year! s. Food wastes for
  restraints and food processors will n! o longer be accepted by landfills 
  in many states past December 31, 2000. The solution to these problems
  represents an major multi-billion dollar opportunity.


  EPTC was established to solve environmental problems regarding the safe
  conversion and removal of waste created by large livestock, poultry, and
  food producers and similar operations.


  Environmental Products & Technologies Corporation (EPTC) is a diversified
  agribusiness manufacturing company has developed and is selling a
  Closed-loop Waste Management Process for livestock operations and food 
  production that solves this waste problem. The system separates solid from
  liquid, processing the solids into an extent-pathogen-free, nutrient-rich
  soil amendment in less than three days -- in contrast to weeks or months for
  conventional systems.


  In early December 1999 EPTC announced a sale of Closed-loop Waste
  Management System for use in process! ing food waste from various supermarkets 
  and restaurants on the island of Oahu. The sale, valued in excess of $500,000
  provides for delivery and installation of a dual vessel Bioreactor system
  during the first quarter of 2000. The system is capable of processing
  approximately 25 tons of organic waste (including food, dairy, and green
  waste) per day. The purchaser anticip ates the purchase of up to 20
  additional systems after the initial systems are operating at full capacity.
  That could mean additional sales of $4 million to this one customer
  alone.


  A recent strong buy recommendation given to EPTC by The Phoenix Group 
  International and Wall Street Corner is one that should not be ignored. At a 
  recent price of $2.50 per share down from over $10.00 in mid-1999, the stock ( based on 
  recent chart action) looks to be ready for a move to the upside. Based on information
  announced by the company and the recently updated research report, the stock 
  ( http://208.142.202.16/eptctwo.html ) has potential for a move to new highs as the backlog of contracts
  for its waste manage system is anticipated to grow in the coming months.


  We believe that now is the time to take a close look at the
  shares of EPTC ( http://208.142.202.16/eptc.html ) . Approximately 8.5 million 
  shares outstanding and a $20 million market capitalization. Based on EPTC's 
  statement that it could sell and install close to 50 units during in 2000 the company 
  is selling at about 1.2 times anticipated sales. The multi-billion market for the company's
  products could produce extremely rapid growth from a flood of customers in
  great need of a solution to keep their businesses operational come January
  2001.



  The buy recommendation points out that EPTC's time has come. This does
  not refer solely to product design or the company's ability to deliver at least
  50 complete systems in the during 2000. It is expected that each of these
  systems will range for $250,000 t o $450,000 depending on the specific
  needs of the customer.


  The time has come refers to the attitude that consumers and even more
  importantly government at all levels has finally adopted.
  Laws and rules that have been on the books for years are finally receiving
  major attention and are starting to be enforced to the letter of the law.


  Government has also recognized that some of these laws are changes to
  prior rules and enforcement attitudes. To help encourage business and farms to
  invest in modern waste handling system they have provided financing
  programs to many regions in t! he form of very favorable long term, low
  cost loans, and! bond financing.


  Food wastes produced by food processors and restaurants in many cities
  and states such as California will soon no longer be accepted at land fills
  after December 31, 2000.


  This waste will require special handling and in many cases the EPTC Closed
  Loop Waste Management system may be the only alternative. The needs of
  the high density hog, dairy, and cattle raising industry have been highlighted
  by many problems this past year. The most important to regulators in the
  potential damage that these operation may cause to the water supply if the
  waste in not handled in a safe manner.


  This is not a recommendation to buy or sell the shares of Environmental
  Products and Technologies. The shares of this company should be
  considered high risk. This notice serves as a bulletin to advise our readers of a 
  possible opportunity in the environmental waste management business.


  We advise our readers to always research carefully and consult
  an investment professional before making investment decisions. For
  additional information investors should read the latest research report at
  http://208.142.202.16/eptctwo.html

Web Site could be down due to re-construction. If so lookup charts anywhere.

  or send us an E-mail at stocksavvyforum@myanmars.com
  or call (888) 323-0856 for more info today.